Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  5
 Total visitors :  7471437

EFSA Releases Assessments of Two GM Maize for Food and Feed Uses
Wednesday, 2024/01/31 | 07:58:33

The European Food Safety Authority (EFSA) Panel on Genetically Modified Organisms (GMO Panel) has published the Scientific Opinion which reports on the outcome of its risk assessment of two genetically modified (GM) maize, DP23211 from Corteva Agriscience Belgium, and DP915635 from Pioneer Hi-Bred International.

 

Application EFSA-GMO-NL-2019-163 under Regulation (EC) No 1829/2003 for maize DP23211 is for import, processing, and food and feed uses within the European Union (EU) and does not include cultivation. The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the IPD072Aa, PAT, and PMI proteins and the DvSSJ1 dsRNA and derived siRNAs newly expressed in maize DP23211.

 

Application FSA-GMO-NL-2020-172 under Regulation (EC) No 1829/2003 is also for import, processing, and food and feed uses within the EU of maize DP915635 and does not include cultivation. The GMO Panel does not identify safety concerns regarding the toxicity and allergenicity of the IPD079Ea, PAT, and PMI proteins as expressed in maize DP915635.

 

According to the Scientific Opinion, the consumption of food and feed from maize DP23211 and DP915635 does not represent a nutritional concern in humans and animals. The GMO Panel concludes that maize DP23211 and DP915635 are as safe as their conventional counterparts and the tested non-GM maize reference varieties for potential effects on human and animal health and the environment.

 

For more details, read the Scientific Opinion for GM maize DP23211 and DP915635 published in the EFSA Journal.

See https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=20606

 

Back      Print      View: 100

[ Other News ]___________________________________________________
  • Egypt Holds Workshop on New Biotech Applications
  • UN Agencies Urge Transformation of Food Systems
  • Taiwan strongly supports management of brown planthopper—a major threat to rice production
  • IRRI Director General enjoins ASEAN states to invest in science for global food security
  • Rabies: Educate, vaccinate and eliminate
  • “As a wife I will help, manage, and love”: The value of qualitative research in understanding land tenure and gender in Ghana
  • CIP Director General Wells Reflects on CIP’s 45th Anniversary
  • Setting the record straight on oil palm and peat in SE Asia
  • Why insect pests love monocultures, and how plant diversity could change that
  • Researchers Modify Yeast to Show How Plants Respond to Auxin
  • GM Maize MIR162 Harvested in Large Scale Field Trial in Vinh Phuc, Vietnam
  • Conference Tackles Legal Obligations and Compensation on Biosafety Regulations in Vietnam
  • Iloilo Stakeholders Informed about New Biosafety Regulations in PH
  • Global wheat and rice harvests poised to set new record
  • GM Maize Harvested in Vietnam Field Trial Sites
  • New label for mountain products puts premium on biological and cultural diversity
  • The Nobel Prize in Physiology or Medicine 2016
  • Shalabh Dixit: The link between rice genes and rice farmers
  • People need affordable food, but prices must provide decent livelihoods for small-scale family farmers
  • GM Seeds Market Growth to Increase through 2020 Due to Rise in Biofuels Use

 

Designed & Powered by WEBSO CO.,LTD